Schedule 13G ownership disclosure
Trillium Therapeutics Inc.
Security class unavailable · CUSIP: 89620X605
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,243,313
- Percent of class
- 1.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895421-20-000350
- Form type
- SC 13G
- Filer
- MORGAN STANLEY
- CIK
- CIK 895421
- Filed
- May 11, 2020
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership